SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

Go back to SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026
(NASDAQ: ICU) Delayed: 3.09 --0 (-0%)
Previous Close $3.09    52 Week High $1.99 
Open $3.09    52 Week Low $1.99 
Day High $3.09    P/E 12.36 
Day Low $3.09    EPS $0.25 
Volume